Priority Date: 20.12.11 (US 201161577707P)

2',4'-DIFLUORO-2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION

  • Application ID: EP12810206
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Vossius & Partner Patentanwälte Rechtsanwälte mbB is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB, Isenbruck Bösl Hörschler LLP and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 20.12.2011 - Priority Date (US 201161577707P)
  • 27.06.2013 - Publication A1 (WO2013092481)
  • 29.10.2014 - Publication A1 (EP2794629)
  • 24.05.2017 - Publication B1 (EP2794629)

IPC Classification